Actinium Pharmaceuticals Inc ATNM:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
8.93quote price arrow down-0.03 (-0.33%)
Volume
10,271
Close
8.96quote price arrow up+0.21 (+2.40%)
Volume
516,106
52 week range
4.00 - 9.86
Loading...
  • Open8.95
  • Day High9.20
  • Day Low8.54
  • Prev Close8.75
  • 52 Week High9.86
  • 52 Week High Date03/22/24
  • 52 Week Low4.00
  • 52 Week Low Date11/28/23

Key Stats

  • Market Cap266.86M
  • Shares Out29.78M
  • 10 Day Average Volume0.29M
  • Dividend-
  • Dividend Yield-
  • Beta0.11
  • YTD % Change76.38

KEY STATS

  • Open8.95
  • Day High9.20
  • Day Low8.54
  • Prev Close8.75
  • 52 Week High9.86
  • 52 Week High Date03/22/24
  • 52 Week Low4.00
  • 52 Week Low Date11/28/23
  • Market Cap266.86M
  • Shares Out29.78M
  • 10 Day Average Volume0.29M
  • Dividend-
  • Dividend Yield-
  • Beta0.11
  • YTD % Change76.38

RATIOS/PROFITABILITY

  • EPS (TTM)-1.72
  • P/E (TTM)-5.21
  • Fwd P/E (NTM)-4.53
  • EBITDA (TTM)-49.109M
  • ROE (TTM)-91.92%
  • Revenue (TTM)81,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-57,346.91%
  • Debt To Equity (MRQ)0.06%

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Actinium Pharmaceuticals Inc

 

Profile

MORE
Actinium Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing targeted radiotherapies to improve survival for people who have failed existing oncology therapies. The Company’s advanced pipeline candidates include Iomab-B (pre-BLA & MAA (EU)) and Actimab-A. Iomab-B is an induction and conditioning agent prior to bone marrow transplant. Actimab-A is a therapeutic agent, have demonstrated potential to extend survival outcomes for...
Sandesh Seth
Chairman of the Board, Chief Executive Officer
Steve O'Loughlin
Chief Financial Officer
Address
100 Park Ave., 23Rd Floor
New York, NY
10017
United States

Top Peers

SYMBOLLASTCHG%CHG
ALDX
Aldeyra Therapeutics Inc
4.16-0.05-1.19%
PRLD
Prelude Therapeutics Inc
3.86-0.13-3.26%
INMB
INmune Bio Inc
11.57+0.44+3.95%
QSI
Quantum-Si Inc
1.84+0.08+4.55%
OVID
Ovid Therapeutics Inc
3.06-0.01-0.33%